Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Frontiers in Genetics|January 8, 2021
Identification of Hub Genes Associated With Development and Microenvironment of Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis and Differential Gene Expression AnalysisQingquan Bai, Haoling Liu, Hongyu Guo, et al.
Molecular Cancer|June 3, 2014
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular CarcinomaTongsen Zheng, Dalong Yin, Zhaoyang Lu, et al.
Oncotarget|September 28, 2014
The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathwayJiabei Wang, Dalong Yin, Changming Xie, et al.
Oxidative Medicine and Cellular Longevity|June 9, 2021
PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS ProductionChaoqun Wang, Zihao Li, Baolei Zhao, et al.
Free Radical Biology & Medicine|December 4, 2020
The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinomaChaoqun Wang, Liqian Dong, Xiaozhuang Li, et al.
Oncogenesis|July 19, 2022
NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axisShounan Lu, Shanjia Ke, Chaoqun Wang, et al.
Cell Death & Disease|April 28, 2018
PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effectDan Li, Chaoqun Wang, Panfei Ma, et al.
Chinese Medical Journal|January 17, 2025
Arsenic trioxide preconditioning attenuates hepatic ischemia- reperfusion injury in mice: Role of ERK/AKT and autophagyChaoqun Wang, Hongjun Yu, Shounan Lu, et al.
Hepatology (Baltimore, Md.)|September 17, 2013
Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinomaTongsen Zheng, Xuehui Hong, Jiabei Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 27, 2023
TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophagesJingjing Huang, Huayang Pan, Jing Sun, et al.
Pageof 14